Bush Boosts Budget For Bioterrorism Research and Defense
Filed in archive Corporate and Industrial News , Other Biotechnology News on February 9, 2006
There is a healthy discussion on the FuturePundit blog regarding Bush administration's medical research budget freeze.
Where is the Federal money getting channeled to? Bio-defense reasearch.
New England's security and defense sector would reap billions of dollars under President Bush's latest budget proposal, while the region's biotechnology industry would benefit from an infusion of federal research dollars, according to administration documents and local industry officials.
The National Institutes of Health's proposed $28.4 billion budget would include $1.9 billion for bio-defense research, including $160 million for advanced development of medical countermeasures against bio-terrorism, according to the documents.
Local officials are already excited with the pending infusion of funds. Locals don't seem to be too elated, however, at having Level 4 federal biodefense laboratories operating in their midst.
The National Institutes of Health's proposed $28.4 billion budget would include $1.9 billion for bio-defense research, including $160 million for advanced development of medical countermeasures against bio-terrorism, according to the documents.
Tags: bioterrorism bioweapon biotech research defense research+defense bush+boosts bioterrorism+research
Vote for Bush Boosts Budget For Bioterrorism Research and Defense:
|
Rating: 8.00 out of 4 vote(s) cast.
|
Response from:
Michelle Laird
(01/22/07 7:14pm)
Response from:
Michelle Laird
(01/22/07 7:17pm)
Here is where some of the biodefensive money is going...and it is money well spent. The DOD has granted Seattle company Inologic $1.1M to develop a radioprotective drug that could either act before radiation exposure to protect the body from radiation damage or act as a type of “morning after” drug and help repair damage once it has occurred. The drug could potentially protect U.S. troops and protect the public if exposed to radioactive material.
In light of recent events such as the public health scare associated with the radiation contamination of ex-Russian spy Alexander Litvinenko, who died of exposure to the radioactive material polonium-210, the availability of such a radioprotective drug could have significant health benefits.
www.Inologic.com.
In light of recent events such as the public health scare associated with the radiation contamination of ex-Russian spy Alexander Litvinenko, who died of exposure to the radioactive material polonium-210, the availability of such a radioprotective drug could have significant health benefits.
www.Inologic.com.
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
In light of recent events such as the public health scare associated with the radiation contamination of ex-Russian spy Alexander Litvinenko, who died of exposure to the radioactive material polonium-210, the availability of such a radioprotective drug could have significant health benefits.
For more on this announcement, visit Inologic.com.